CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products. - Cruz CN; Tyner KM; Velazquez L; Hyams KC; Jacobs A; Shaw AB; Jiang W; Lionberger R; Hinderling P; Kong Y; Brown PC; Ghosh T; et al. (The AAPS journal, 2013)